// App-Quantinova.ai

3560 : Prospective analysis of CEA, circulating DNA (cDNA) and circulating tumor cells (CTC) kinetics in patients (pts) treated for a metastatic colorectal cancer (mCRC).

Researchers

Presenter

  • David Sefrioui

Principal Investigators

  • Nasrin Sarafan-Vasseur

  • Emmanuel Toure

  • Julien Delacour

  • Frederic Ziegler

  • Caroline Thill

  • Alice Gangloff

  • France Blanchard

  • Ludivine Beaussire

  • Karine Bouhier Leporrier

  • Marie-Pierre Galais

  • Anne Perdrix

  • Florian Clatot

  • Fabrice Jardin

  • Jean-Christophe Sabourin

  • Thierry Frebourg

  • Pierre Michel

  • Frederic Di Fiore

Medical Centers

  • Digestive Oncology Unit, IRON group, Rouen Hospital, University of Normandy, Rouen, France

  • INSERM, U1079, IRON group, University of Normandy, Rouen, France

  • Department of Pathology, University of Normandy, Rouen, France

  • INSERM, U1079, IRON group, University of Normandy, Rouen, France

  • Institute of Clinical Biology, INSERM UMR 1073, University of Normandy, Rouen, France

  • Department of Biostatistics, University of Normandy, Rouen, France

  • Department of Pathology, Rouen University Hospital, Rouen, France

  • Centre Hospitalier Universitaire Cote de Nacre, Caen, France

  • Digestive Oncology Unit, Centre Francois Baclesse, University of Normandy, Caen, France

  • Department of Bio-Pathology,IRON group, Centre Henri Becquerel, Rouen, France

  • INSERM U918, IRON group, Centre Henri Becquerel, University of Normandy, Rouen, France

  • Department of hematology, Inserm U918, Centre henri Becquerel, University of Normandy, Rouen, France

  • Department of Pathology, IRON group, Rouen Hospital, University of Normandy, Rouen, France

  • INSERM, U1079, IRON group, University of Normandy, Rouen, France

  • Digestive Oncology Unit, IRON group, Rouen Hospital, University of Normandy, Rouen, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal Cancer

Biomarkers

  • Carcinoembryonic antigen

  • Circulating tumor cells

  • Circulating DNA

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final